The center is slated to open in 2014.
Dr. Colombel also serves as a professor of medicine and gastroenterology at the Icahn School of Medicine at Mount Sinai. He is renowned for his role in identifying NOD2 as a susceptibility gene for Crohn’s disease and the identification of a new subtype of E. coli associated with Crohn’s.
Dr. Colombel has authored more than 500 peer-reviewed articles, books and chapters on inflammatory bowel disease. Recently he also was a professor of hepatogastroenterology at Centre Hospitalier Universitaire de Lille in France and the president of the European Crohn’s and Colitis Organization.
More Articles on Gastroenterology:
Hallmark Health’s New Gastroenterology Location Opens in Massachusetts
Kansas Hospital Tests Patients for Hepatitis, HIV After Administering Colonoscopies With Potentially Contaminated Scopes
Dr. Dennis Yamamoto of Digestive Health Associates Named a Top 100 Influential Figure
